Concepedia

Siebe Loontiens

SL

Statistics

Publications

11

Citations

364

H-Index

11

Active since

2018

Affiliations

Cancer Research Institute Ghent(Current)

Ghent University

Ghent University Hospital

Harvard Stem Cell Institute

Charité - Universitätsmedizin Berlin

Siebe Loontiens is an author at Cancer Research Institute Ghent specializing in cell biology, medicine, and cell signaling.

ORCID

Top concepts

Publications per year

2018–2025

11

Publications

11

TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets

Bieke Decaesteker, Geertrui Denecker, Christophe Van Neste et al. · Nature Communications · 2018 · 108 citations · Full text

RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

Carolina Nunes, Lisa Depestel, Liselot Mus et al. · Science Advances · 2022 · 44 citations · Full text

, , +17

Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia

Saara Laukkanen, Alexandra Veloso, Chuan Yan et al. · Blood · 2022 · 41 citations · Full text

SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry

Bieke Decaesteker, Amber Louwagie, Siebe Loontiens et al. · Nature Communications · 2023 · 39 citations · Full text

Cell of origin dictates aggression and stem cell number in acute lymphoblastic leukemia

Elaine G. Garcia, Sowmya Iyer, Sara P. Garcia et al. · Leukemia · 2018 · 26 citations · Full text

, , +12

1–5 of 11